Information  X 
Enter a valid email address

Astrazeneca PLC Ord (AZN)

Related News

11-Aug-2021 03:05 PM

AstraZeneca announces update on new chronic kidney disease drug

StockMarketWire.com AstraZeneca has announced the US Food and Drug Administration (FDA) has issued a complete response letter regarding its new drug application for roxadustat. Roxadustat is a treatment of anaemia of chronic kidney disease, in bot
18-May-2021 07:06 AM

Oxford Biomedica ups earnings guidance as AstraZeneca increases vaccine order

Gene and cell therapy group Oxford Biomedica upgraded its annual earnings guidance after AstraZeneca increased the size of an order related to Covid-19 vaccines. Oxford Biomedica had in September signed an 18-month supply agreement with AstraZeneca for
30-Apr-2021 07:37 AM

AstraZeneca revenue climbs in Q1 on stronger performance in new medicines

Pharmaceutical giant AstraZeneca reported a rise in first quarter, driven by performance in new medicines across oncology and bioPharmaceuticals. For the first quarter of the year, revenue was up 15% to $7.32 billion as product sales increased 15% to $7
16-Apr-2021 03:00 PM

AstraZeneca receives US clearance for proposed acquisition of Alexion

AstraZeneca's proposed acquisition of Alexion Pharmaceuticals has been cleared by the US Federal Commission, following the end of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The announcement follows competition cleara
30-Mar-2021 01:06 PM

AstraZeneca rearrange AGM to May

Pharmaceutical giant AstraZeneca has released information regarding its upcoming annual general meeting. The firm had previously announced that the meeting was to be held on 30 April 2021, however, the AGM will now be held on Tuesday 11 May 2021 at 11.00
08-Dec-2020 01:31 PM

AstraZeneca signs Covid-19 vaccine manufacturing deal

AstraZeneca has signed a deal with Dutch firm Halix for the large-scale commercial manufacture of its Covid-19 vaccine AZD1222. Under the agreement, Halix will provide commercial manufacturing of drug substances at its Leiden Bio Science Park facility in
10-Nov-2020 07:26 AM

AstraZeneca announces positive results from asthma drug trial

AstraZeneca and Amgen announced positive results from the NAVIGATOR Phase III trial for the potential new medicine tezepelumab in patients with severe, uncontrolled asthma. NAVIGATOR met the primary endpoint with tezepelumab added to standard of care (So
09-Nov-2020 07:37 AM

Astra's chronic lymphocytic leukaemia treatment gets EU clearance

AstraZeneca's said its drug Calquence had received European Union approval for the treatment of adult patients with chronic lymphocytic leukaemia (CCL) adding to approvals already received in the US and several other countries worldwide. In Phase th
03-Aug-2020 08:20 AM

Broker Forecast - Credit Suisse issues a broker note on AstraZeneca PLC

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9500p (from 9000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jul-2020 12:10 PM

Broker Forecast - DZ Bank issues a broker note on AstraZeneca PLC

DZ Bank today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7500p (from 7300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Jul-2020 08:20 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9300p (from 9200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
28-Jul-2020 10:42 AM

CORRECTION: AstraZeneca cancer treatments secure positive CHMP recommendations in EU

Pharmaceutical company AstraZeneca said its chronic leukaemia and lung cancer treatments had been recommended for marketing authorisation in the European Union. The positive recommendation for Imfinzi plus chemotherapy to treat small cell lung cancer and
22-Jun-2020 12:20 PM

Broker Forecast - Oddo issues a broker note on AstraZeneca PLC

Oddo today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to reduce (from buy) and cut its price target to 7600p (from 8100p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-Jun-2020 11:40 AM

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7300p (from 6000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-Jun-2020 10:10 AM

Broker Forecast - Bryan Garnier issues a broker note on AstraZeneca PLC

Bryan Garnier today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9100p (from 8780p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-May-2020 11:00 AM

Broker Forecast - Bryan Garnier issues a broker note on AstraZeneca PLC

Bryan Garnier today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8780p (from 8550p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-May-2020 10:50 AM

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7575p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
01-May-2020 04:00 PM

Broker Forecast - DZ Bank issues a broker note on AstraZeneca PLC

DZ Bank today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7300p (from 6500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
01-May-2020 02:20 PM

Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9500p (from 8500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
01-May-2020 01:10 PM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9200p (from 9000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Apr-2020 11:20 AM

Broker Forecast - Credit Suisse issues a broker note on AstraZeneca PLC

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9000p (from 8500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Apr-2020 11:10 AM

Broker Forecast - HSBC issues a broker note on AstraZeneca PLC

HSBC today reaffirms its reduce investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6690p (from 6450p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
21-Apr-2020 02:10 PM

Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 7700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Apr-2020 02:40 PM

Broker Forecast - Mainfirst issues a broker note on AstraZeneca PLC

Mainfirst today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8800p (from 8100p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Apr-2020 02:30 PM

Broker Forecast - Morgan Stanley issues a broker note on AstraZeneca PLC

Morgan Stanley today reaffirms its equal weight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8600p (from 8250p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...

a d v e r t i s e m e n t